Literature DB >> 18698592

Nicotinic acetylcholine receptor subunit mRNA expression in adult and developing rat medullary catecholamine neurons.

Kathryn T O'Leary1, Sandra E Loughlin, Yiling Chen, Frances M Leslie.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) mediate numerous visceral functions via medullary catecholamine (CA) neurons found in the nucleus tractus solitarius (NTS), dorsal motor nucleus of the vagus (DMV), and ventrolateral medulla (VLM). However, the nAChR subtypes involved are not known. We have therefore characterized expression of nine nAChR subunit mRNAs in adult and developing rat medullary CA nuclei using combined isotopic/nonisotopic in situ hybridization. Tyrosine hydroxylase (TH) mRNA, the CA-synthesizing enzyme, was used as a marker for CA neurons, because these nuclei consist of heterogeneous populations of cells. Subunit mRNA expression varied within and between nuclei, along the rostrocaudal axis, between cell types, and across development. All CA neurons expressed beta2 mRNA, whereas alpha2 mRNA was completely absent. alpha6 And beta3 mRNA expression were restricted mainly to the VLM. alpha4, alpha5, And alpha7 mRNA expression was significantly greater in the rostral than in the caudal VLM. alpha3 And beta4 mRNAs were highly expressed in the dorsal region of the NTS, whereas dense alpha7 mRNA expression was restricted to the DMV and ventral NTS. The remaining subunit mRNAs were detected to some degree in both DMV and NTS. Except for alpha4 mRNA, which peaked prenatally, expression levels of subunit transcripts in the NTS and DMV were lower during development compared with adults. In the VLM, alpha3, alpha4, and alpha5 mRNAs expression peaked perinatally, whereas alpha6 and beta3 levels increased with age. These variations in nAChR subunit mRNA expression suggest that different receptor subtypes may produce function-specific regulation of medullary CA systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698592     DOI: 10.1002/cne.21833

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

Authors:  Alvin V Terry; Jerry J Buccafusco; R Foster Schade; Leah Vandenhuerk; Patrick M Callahan; Wayne D Beck; Elizabeth J Hutchings; James M Chapman; Pei Li; Michael G Bartlett
Journal:  Biochem Pharmacol       Date:  2012-01-08       Impact factor: 5.858

2.  Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.

Authors:  Andrew M Smith; Linda P Dwoskin; James R Pauly
Journal:  J Pediatr Biochem       Date:  2010

3.  Altered Cortical Brain Structure and Increased Risk for Disease Seen Decades After Perinatal Exposure to Maternal Smoking: A Study of 9000 Adults in the UK Biobank.

Authors:  Lauren E Salminen; Rand R Wilcox; Alyssa H Zhu; Brandalyn C Riedel; Christopher R K Ching; Faisal Rashid; Sophia I Thomopoulos; Arvin Saremi; Marc B Harrison; Anjanibhargavi Ragothaman; Victoria Knight; Christina P Boyle; Sarah E Medland; Paul M Thompson; Neda Jahanshad
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

4.  Signal intensities of radiolabeled cRNA probes used alone or in combination with non-isotopic in situ hybridization histochemistry.

Authors:  Jong-Hyun Son; Ursula H Winzer-Serhan
Journal:  J Neurosci Methods       Date:  2009-02-04       Impact factor: 2.390

Review 5.  The dynamic effects of nicotine on the developing brain.

Authors:  Jennifer B Dwyer; Susan C McQuown; Frances M Leslie
Journal:  Pharmacol Ther       Date:  2009-03-05       Impact factor: 12.310

6.  Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats.

Authors:  Anne-Sophie Villégier; Brittney Gallager; Jon Heston; James D Belluzzi; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.